Author:
Wilder-Smith Annelies,Vannice Kirsten,Durbin Anna,Hombach Joachim,Thomas Stephen J.,Thevarjan Irani,Simmons Cameron P.
Publisher
Springer Science and Business Media LLC
Reference83 articles.
1. Heymann DL, Hodgson A, Sall AA, Freedman DO, Staples JE, Althabe F, Baruah K, Mahmud G, Kandun N, Vasconcelos PF, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet. 2016;387(10020):719–21.
2. World Health Organization. WHO and Experts Prioritize Vaccines, Diagnostics and Innovative Vector Control Tools for Zika R&D.
http://www.who.int/mediacentre/news/notes/2016/research-development-zika/en
. Accessed Jan 2018.
3. Durbin AP. Vaccine development for Zika Virus – timelines and strategies. Semin Reprod Med. 2016;34(5):299–304.
4. Durbin A, Wilder-Smith A. An update on Zika vaccine developments. Expert Rev Vaccines. 2017;16(8):781–7.
5. World Health Organization. WHO Zika Virus (ZIKV) Vaccine Target Product Profile (TPP): Vaccine to Protect Against Congenital Zika Virus Syndrome for Use During an Emergency. Geneva: WHO/UNICEF; 2016.
Cited by
70 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献